The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 343:1654-1656 November 30, 2000 Number 22
NextNext

Pulmonary Langerhans'-Cell Histiocytosis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Arens, R.
-Related Article
 by Vassallo, R.
-PubMed Citation
To the Editor: Vassallo et al. (June 29 issue)1 depict a central role for the alveolar macrophage in the pathogenesis of pulmonary Langerhans'-cell histiocytosis. We made several observations in a series of five patients with biopsy-proved, CD1a+ pulmonary Langerhans'-cell histiocytosis at our institution. The patients were all young adults (age range, 22 to 31 years) who had smoked cigarettes. On histologic analyses, there were CD68+ histiocytes, including macrophages with "smoker's granules," admixed with Langerhans' cells; angiotensin-converting–enzyme (ACE) antigen was expressed on non–Langerhans'-cell histiocytes within the lesion and surrounding alveoli. Histiocytes from a lesion of Langerhans'-cell histiocytosis were positive for the . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.